Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

AMGN

Amgen (AMGN)

Amgen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:BIT:AMGN
DateTimeSourceHeadlineSymbolCompany
20/10/200905:57Dow Jones News2nd UPDATE: FDA Delays Decision On Amgen Bone DrugNASDAQ:AMGNAmgen Inc.
20/10/200902:17Dow Jones NewsUPDATE: FDA Delays Decision On Amgen Bone Drug For Added InfoNASDAQ:AMGNAmgen Inc.
20/10/200900:55Dow Jones NewsFDA Seeks Added Info On Amgen Bone Drug, Delays DecisionNASDAQ:AMGNAmgen Inc.
17/10/200905:55Dow Jones NewsUS EQUITIES WEEK AHEAD: More 3Q Results; Windows 7 LaunchesNASDAQ:AMGNAmgen Inc.
15/10/200905:44Dow Jones NewsAmgen's Bone Drug May Face Delays In FDA DecisionNASDAQ:AMGNAmgen Inc.
13/10/200901:57Dow Jones NewsDrug Stocks Edge Higher; DepoMed SinksNASDAQ:AMGNAmgen Inc.
02/10/200903:22Dow Jones NewsHospira Learning Valuable Lessons In European Biosimilar MarketNASDAQ:AMGNAmgen Inc.
24/09/200900:22Dow Jones NewsConflicting Erbitux Study Data Hurts Merck SharesNASDAQ:AMGNAmgen Inc.
23/09/200919:59Dow Jones NewsMerck Shares Rise On Positive Erbitux Data For Colon CancerNASDAQ:AMGNAmgen Inc.
22/09/200921:28Dow Jones NewsAmgen's Denosumab Aids Bones In Breast-Cancer PatientsNASDAQ:AMGNAmgen Inc.
18/09/200906:04Dow Jones NewsAmgen Hiring Mobile Reps In Building Bone Drug Sales ForceNASDAQ:AMGNAmgen Inc.
17/09/200923:31Dow Jones NewsMerck KGaA's Erbitux Data May Be Upstaged By Rival VectibixNASDAQ:AMGNAmgen Inc.
16/09/200907:52Dow Jones News2nd UPDATE: US Court Won't Disturb Injunction Against Roche Anemia DrugNASDAQ:AMGNAmgen Inc.
16/09/200907:39Dow Jones NewsUPDATE: US Court Won't Disturb Injunction Against Roche Anemia DrugNASDAQ:AMGNAmgen Inc.
16/09/200902:22Dow Jones NewsUS Court Won't Disturb Injunction Against Roche Anemia DrugNASDAQ:AMGNAmgen Inc.
26/08/200907:46Dow Jones NewsAmgen: Aranesp Doesn't Show Significant Bad Effects In StudyNASDAQ:AMGNAmgen Inc.
17/08/200923:40Dow Jones NewsEuropean Biosimilars Market May Hint At Limited US ThreatNASDAQ:AMGNAmgen Inc.
15/08/200901:29Dow Jones NewsSUBSCRIBERS: FDA OKs Saphris News Already ReportedNASDAQ:AMGNAmgen Inc.
14/08/200909:34Dow Jones News5th UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
14/08/200908:51Dow Jones News4th UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
14/08/200908:03Dow Jones News3rd UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
14/08/200907:13Dow Jones News2nd UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
14/08/200906:10Dow Jones NewsUPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
14/08/200905:38Dow Jones NewsFDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
12/08/200902:56Dow Jones NewsFDA: Amgen Osteoporosis Drug Could Affect Immune SystemNASDAQ:AMGNAmgen Inc.
08/08/200903:01Dow Jones NewsAmgen's Cancer News Promising, But Bone Drug Still The FocusNASDAQ:AMGNAmgen Inc.
05/08/200905:43Dow Jones NewsUPDATE: FDA: Requires Stronger Warnings For TNF Blocker DrugsNASDAQ:AMGNAmgen Inc.
05/08/200904:05Dow Jones NewsFDA: Requires Stronger Class Warnings For TNF Blocker DrugsNASDAQ:AMGNAmgen Inc.
05/08/200902:13Dow Jones NewsAmgen's Positive Bone Drug Data Missed Some High ExpectationsNASDAQ:AMGNAmgen Inc.
04/08/200908:01Dow Jones NewsAmgen Bone Drug Shows Promise In Phase 3 TrialNASDAQ:AMGNAmgen Inc.
 Showing the most relevant articles for your search:BIT:AMGN